Cargando…

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Detalles Bibliográficos
Autores principales:	Zhang, Haibo, Penninger, Josef M., Li, Yimin, Zhong, Nanshan, Slutsky, Arthur S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Understanding the Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079879/ https://www.ncbi.nlm.nih.gov/pubmed/32125455 http://dx.doi.org/10.1007/s00134-020-05985-9

Ejemplares similares

Targeting TMPRSS2 in SARS-CoV-2 Infection
por: Baughn, Linda B., et al.
Publicado: (2020)

Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?
por: Guillon, A., et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
por: Kuba, Keiji, et al.
Publicado: (2021)

Paediatric Inflammatory Multisystem Syndrome Temporally-Associated with SARS-CoV-2 Infection: An Overview
por: Carter, Michael J., et al.
Publicado: (2020)

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
por: Kuba, Keiji, et al.
Publicado: (2005)

On the essentiality of the angiotensin converting enzyme 2 receptor for SARS‐CoV‐2 infection and the potential of soluble angiotensin converting enzyme 2 proteins as universal approach for variants causing COVID‐19
por: Hassler, Luise, et al.
Publicado: (2022)

Angiotensin-converting enzyme 2 in lung diseases
por: Kuba, Keiji, et al.
Publicado: (2006)

Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
por: Sharifkashani, Sourena, et al.
Publicado: (2020)

The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection
por: Schieffer, Elisabeth, et al.
Publicado: (2022)

Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012)

Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
por: Bian, Jingwei, et al.
Publicado: (2021)

SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer’s disease
por: Lukiw, Walter J.
Publicado: (2021)

Angiotensin Converting Enzyme 2 - at the Heart of the COVID-19 pandemic
por: Oudit, Gavin Y., et al.
Publicado: (2023)

Understanding negative pressure pulmonary edema
por: Lemyze, Malcolm, et al.
Publicado: (2014)

From febrile pancytopenia to hemophagocytic lymphohistiocytosis-associated organ dysfunction
por: Carcillo, Joseph A., et al.
Publicado: (2017)

Understanding adrenal crisis
por: Amrein, Karin, et al.
Publicado: (2017)

Understanding renal recovery
por: Bell, Max, et al.
Publicado: (2017)

Understanding ethical decisions for patients on extracorporeal life support
por: Bein, Thomas, et al.
Publicado: (2017)

Ten tips to optimize weaning and extubation success in the critically ill
por: Jung, Boris, et al.
Publicado: (2020)

Bacterial and fungal superinfections in critically ill patients with COVID-19
por: Bassetti, Matteo, et al.
Publicado: (2020)

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Understanding resistance in Pseudomonas
por: Dimopoulos, George, et al.
Publicado: (2020)

Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19
por: Joly, Bérangère S., et al.
Publicado: (2020)

Pulmonary complications in liver disease
por: Bauer, Michael, et al.
Publicado: (2019)

Climate change, global warming, and intensive care
por: Bein, Thomas, et al.
Publicado: (2019)

Ten diseases you need to know if you want to be a critical care specialist in Hong Kong
por: Joynt, Gavin M., et al.
Publicado: (2014)

Intra-cycle power: is the flow profile a neglected component of lung protection?
por: Marini, John J., et al.
Publicado: (2021)

Post-mortem dissection of COVID-19: a pathogenic role for macrophages?
por: Velu, Prasad P., et al.
Publicado: (2021)

How to manage anticoagulation during extracorporeal membrane oxygenation
por: Levy, Jerrold H., et al.
Publicado: (2022)

Acute right ventricular injury phenotyping in ARDS
por: Zochios, Vasileios, et al.
Publicado: (2022)

Compartmentalisation of immune responses in critical illness: does it matter?
por: Conway Morris, Andrew, et al.
Publicado: (2022)

Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
por: Mehta, Puja, et al.
Publicado: (2022)

Use of Mendelian randomization to better understand and treat sepsis
por: Russell, James A., et al.
Publicado: (2022)

Understanding base excess (BE): merits and pitfalls
por: Langer, Thomas, et al.
Publicado: (2022)

Mechanical power: meaning, uses and limitations
por: Gattinoni, Luciano, et al.
Publicado: (2023)

Resistance to unfractionated heparin in the ICU: evaluation and management options
por: Levy, Jerrold H., et al.
Publicado: (2023)

Targeted immunomodulation: a primer for intensivists
por: Janssen, Malou, et al.
Publicado: (2023)

Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
por: Qiu, Ye, et al.
Publicado: (2020)

Angiotensin-converting enzyme 2 protects from severe acute lung failure
por: Imai, Yumiko, et al.
Publicado: (2005)

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
por: Ni, Wentao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ksh085vpv9dua0ngm8k0oou8nv